Kenneth Reed
M.D., P.C. (Director)
Board of Directors
Minerva Biotechnologies
United States of America
Biography
Dr. Reed received his M.D. from the College of Medicine and Dentistry of New Jersey and completed a residency in Dermatology at Harvard Medical School in Boston, MA. Dr. Reed is a Board Certified Dermatologist, Diplomat of the National Board of Medical Examiners, Fellow of the American Academy of Dermatology and a member of the New England Dermatology Society, American Society for Dermatological Surgery, American Society for Laser Medicine and Surgery and American College of Phlebology. Among his awards are the American Medical Association Physician Recognition Award, the New Jersey Medical College Alumni Award, and the William F. Grupe, Inc. Foundation Award. Dr. Reed has been a Clinical Investigator for Genentech Corporation, Amgen Corporation and Astellas. Dr. Reed has published in numerous peer reviewed journals.
Research Interest
Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medicine.